Centers in Argentina and Brazil to develop mRNA antiviral vaccines – PAHO

PAHO seeks to expand productive capacities and strengthen a value chain in the region to increase access and technological independence of the Americas to vaccines.

RIO DE JANEIRO, BRAZIL - Two centers in Argentina and Brazil are to develop and manufacture antiviral vaccines with messenger RNA technology for Latin America and the Caribbean, the Pan American Health Organization (PAHO) announced Tuesday (21), seeking to reduce the region's dependence on imported supplies.

"We believe that these two centers will contribute proactively to the transfer of knowledge and technology in the region," said PAHO deputy director Jarbas Barbosa, when announcing the initiative in a videoconference.

In Argentina, Sinergium Biotech, a private sector biopharmaceutical company, will partner with mAbxience, which belongs to the same group, to develop and . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?